{
    "hands_on_practices": [
        {
            "introduction": "A diagnostic test's sensitivity and specificity are its intrinsic characteristics, determined in validation studies. However, in the clinic, the crucial question is different: \"Given my patient's positive or negative test result, what is the probability they actually have the disease?\" This practice will guide you through the fundamental process of converting sensitivity ($S_n$), specificity ($S_p$), and disease prevalence ($P$) into the Positive and Negative Predictive Values (PPV and NPV), which directly answer this clinical question. Mastering this calculation is the cornerstone of evidence-based test interpretation .",
            "id": "4954900",
            "problem": "A community clinic is considering adopting a new screening assay for a chronic condition. In the clinic’s target population, the disease prevalence is estimated to be $0.03$. In validation studies, the assay demonstrated sensitivity $0.92$ and specificity $0.95$. Using only the core definitions from probability (including conditional probability and the law of total probability) and the epidemiological definitions of sensitivity, specificity, and prevalence, derive expressions for the Positive Predictive Value (PPV) and Negative Predictive Value (NPV) in terms of sensitivity, specificity, and prevalence. Then compute the numerical values of PPV and NPV for this clinic’s setting. Express both PPV and NPV as decimals between $0$ and $1$. Round each to three significant figures. Finally, provide a one-sentence clinical interpretation for each quantity explaining what it means for a patient’s result in this setting. Report your final numeric answer in the order $\\text{PPV}$, $\\text{NPV}$.",
            "solution": "The problem is valid as it is scientifically grounded, well-posed, and objective. It provides a standard task in biostatistics and epidemiology that can be solved using fundamental principles of probability theory.\n\nLet's define the following events:\n- $D$: The event that a randomly selected individual from the population has the chronic condition.\n- $D^c$: The event that the individual does not have the condition.\n- $T^+$: The event that the assay result for an individual is positive.\n- $T^-$: The event that the assay result for an individual is negative.\n\nThe information provided in the problem statement can be translated into probabilistic terms.\nThe prevalence of the disease, denoted by $P$, is the prior probability of having the disease:\n$$P(D) = P = 0.03$$\nConsequently, the probability of not having the disease is:\n$$P(D^c) = 1 - P(D) = 1 - 0.03 = 0.97$$\n\nThe sensitivity of the assay, denoted by $S_n$, is the conditional probability of a positive test result given that the individual has the disease:\n$$S_n = P(T^+ | D) = 0.92$$\n\nThe specificity of the assay, denoted by $S_p$, is the conditional probability of a negative test result given that the individual does not have the disease:\n$$S_p = P(T^- | D^c) = 0.95$$\n\nThe problem asks for the Positive Predictive Value (PPV) and the Negative Predictive Value (NPV).\n\nThe PPV is the conditional probability that an individual has the disease given a positive test result, i.e., $P(D | T^+)$.\nThe NPV is the conditional probability that an individual does not have the disease given a negative test result, i.e., $P(D^c | T^-)$.\n\nFirst, we derive the expression for the PPV. Using the definition of conditional probability (which is the foundation of Bayes' theorem):\n$$\\text{PPV} = P(D | T^+) = \\frac{P(D \\cap T^+)}{P(T^+)}$$\nThe numerator can be re-written using the definition of conditional probability again: $P(D \\cap T^+) = P(T^+ | D)P(D)$.\nThe denominator, $P(T^+)$, can be expanded using the Law of Total Probability:\n$$P(T^+) = P(T^+ | D)P(D) + P(T^+ | D^c)P(D^c)$$\nWe know $P(T^+ | D) = S_n$ and $P(D) = P$. The term $P(T^+ | D^c)$ is the probability of a false positive. It is related to the specificity, $S_p = P(T^- | D^c)$. Since the test result is either positive or negative for a person without the disease, $P(T^+ | D^c) + P(T^- | D^c) = 1$. Thus, $P(T^+ | D^c) = 1 - S_p$.\nSubstituting these into the expression for $P(T^+)$:\n$$P(T^+) = S_n \\cdot P + (1 - S_p) \\cdot (1 - P)$$\nNow, substituting all parts back into the formula for PPV:\n$$\\text{PPV} = \\frac{P(T^+ | D)P(D)}{P(T^+ | D)P(D) + P(T^+ | D^c)P(D^c)} = \\frac{S_n \\cdot P}{S_n \\cdot P + (1 - S_p) \\cdot (1 - P)}$$\nThis is the general expression for PPV in terms of sensitivity, specificity, and prevalence.\n\nNext, we derive the expression for the NPV. Following a similar procedure:\n$$\\text{NPV} = P(D^c | T^-) = \\frac{P(D^c \\cap T^-)}{P(T^-)}$$\nThe numerator is $P(D^c \\cap T^-) = P(T^- | D^c)P(D^c)$.\nThe denominator, $P(T^-)$, is found using the Law of Total Probability:\n$$P(T^-) = P(T^- | D)P(D) + P(T^- | D^c)P(D^c)$$\nWe know $P(T^- | D^c) = S_p$ and $P(D^c) = 1-P$. The term $P(T^- | D)$ is the probability of a false negative. It is related to the sensitivity, $S_n = P(T^+ | D)$. Since the test result is either positive or negative for a person with the disease, $P(T^+ | D) + P(T^- | D) = 1$. Thus, $P(T^- | D) = 1 - S_n$.\nSubstituting these into the expression for $P(T^-)$:\n$$P(T^-) = (1 - S_n) \\cdot P + S_p \\cdot (1 - P)$$\nNow, substituting all parts back into the formula for NPV:\n$$\\text{NPV} = \\frac{P(T^- | D^c)P(D^c)}{P(T^- | D)P(D) + P(T^- | D^c)P(D^c)} = \\frac{S_p \\cdot (1 - P)}{(1 - S_n) \\cdot P + S_p \\cdot (1 - P)}$$\nThis is the general expression for NPV.\n\nNow we compute the numerical values using the given data: $P = 0.03$, $S_n = 0.92$, $S_p = 0.95$.\n\nFor PPV:\n$$\\text{PPV} = \\frac{0.92 \\cdot 0.03}{0.92 \\cdot 0.03 + (1 - 0.95) \\cdot (1 - 0.03)} = \\frac{0.0276}{0.0276 + 0.05 \\cdot 0.97} = \\frac{0.0276}{0.0276 + 0.0485} = \\frac{0.0276}{0.0761} \\approx 0.362679$$\nRounding to three significant figures, we get $\\text{PPV} \\approx 0.363$.\n\nFor NPV:\n$$\\text{NPV} = \\frac{0.95 \\cdot (1 - 0.03)}{(1 - 0.92) \\cdot 0.03 + 0.95 \\cdot (1 - 0.03)} = \\frac{0.95 \\cdot 0.97}{0.08 \\cdot 0.03 + 0.95 \\cdot 0.97} = \\frac{0.9215}{0.0024 + 0.9215} = \\frac{0.9215}{0.9239} \\approx 0.997402$$\nRounding to three significant figures, we get $\\text{NPV} \\approx 0.997$.\n\nFinally, we provide the one-sentence clinical interpretations for these values.\n\nPPV Clinical Interpretation: For a patient from this population who receives a positive test result, there is a $36.3\\%$ probability that they actually have the chronic condition.\n\nNPV Clinical Interpretation: For a patient from this population who receives a negative test result, there is a $99.7\\%$ probability that they are truly free of the chronic condition.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.363 & 0.997 \\end{pmatrix}}$$"
        },
        {
            "introduction": "The sensitivity and specificity values we use are not universal truths; they are estimates derived from specific studies. This exercise demonstrates the critical concept of \"spectrum bias,\" where the choice of patients in a validation study can significantly alter a test's apparent performance. By comparing a full-spectrum evaluation with a restricted one, you will quantify how including only the most severe cases and certain types of controls can create a misleading picture of a test's accuracy in a real-world clinical setting . This practice highlights the importance of critically appraising the methodology of a diagnostic accuracy study before applying its results.",
            "id": "4954827",
            "problem": "A hospital is evaluating a new point-of-care diagnostic assay for a respiratory infection. The assay yields a binary result (positive versus negative). To probe how the case-mix affects apparent performance, consider the following clinically plausible stratification of patients by disease severity among those truly diseased, and by presentation among those truly non-diseased.\n\nAmong truly diseased patients: mild cases ($200$ patients: $110$ positive, $90$ negative), moderate cases ($150$ patients: $120$ positive, $30$ negative), and severe cases ($100$ patients: $95$ positive, $5$ negative).\n\nAmong truly non-diseased patients: community healthy controls ($250$ patients: $5$ positive, $245$ negative) and symptomatic disease-mimicking patients ($200$ patients: $60$ positive, $140$ negative).\n\nTwo validation designs are considered:\n\n- Full-spectrum evaluation: includes all three diseased strata and both non-diseased strata.\n- Restricted-spectrum evaluation: recruits only severe diseased cases and symptomatic disease-mimicking non-diseased patients.\n\nUsing only the core definitions of sensitivity and specificity (that is, sensitivity is the probability the test is positive given true disease, and specificity is the probability the test is negative given no disease), do the following:\n\n1. Compute the sensitivity and specificity under the full-spectrum evaluation.\n2. Compute the sensitivity and specificity under the restricted-spectrum evaluation.\n3. Define the net spectrum-bias magnitude by\n$$\nB \\equiv \\left(\\text{sensitivity}_{\\text{restricted}} - \\text{sensitivity}_{\\text{full}}\\right) + \\left(\\text{specificity}_{\\text{full}} - \\text{specificity}_{\\text{restricted}}\\right).\n$$\nCompute $B$.\n\nRound your final answer for $B$ to $4$ significant figures and express it as a pure number (no units).",
            "solution": "**Solution Derivation**\n\nThe core definitions for sensitivity and specificity are based on counts of true positives ($TP$), true negatives ($TN$), false negatives ($FN$), and false positives ($FP$). Let $D$ denote the event of having the disease and $D^c$ denote the event of not having the disease. Let $T^+$ and $T^-$ denote positive and negative test results, respectively.\nSensitivity is defined as $P(T^+|D) = \\frac{\\text{Number of } TP}{\\text{Total number of diseased individuals}}$.\nSpecificity is defined as $P(T^-|D^c) = \\frac{\\text{Number of } TN}{\\text{Total number of non-diseased individuals}}$.\n\n**1. Full-Spectrum Evaluation**\nFor this evaluation, we consider all patient strata.\n\nThe total number of truly diseased patients is the sum of patients in the mild, moderate, and severe strata:\n$$N_D = 200 + 150 + 100 = 450$$\nThe total number of true positives ($TP_{full}$) is the sum of positive results across these strata:\n$$TP_{full} = 110 + 120 + 95 = 325$$\nThe sensitivity for the full-spectrum evaluation is therefore:\n$$\\text{sensitivity}_{\\text{full}} = \\frac{TP_{full}}{N_D} = \\frac{325}{450}$$\n\nThe total number of truly non-diseased patients is the sum of patients in the healthy control and disease-mimicking strata:\n$$N_{D^c} = 250 + 200 = 450$$\nThe total number of true negatives ($TN_{full}$) is the sum of negative results across these strata:\n$$TN_{full} = 245 + 140 = 385$$\nThe specificity for the full-spectrum evaluation is therefore:\n$$\\text{specificity}_{\\text{full}} = \\frac{TN_{full}}{N_{D^c}} = \\frac{385}{450}$$\n\n**2. Restricted-Spectrum Evaluation**\nFor this evaluation, we only consider severe diseased cases and symptomatic disease-mimicking non-diseased patients.\n\nThe number of truly diseased patients is the number of severe cases:\n$$N'_D = 100$$\nThe number of true positives ($TP_{restr}$) is the number of positive results in the severe stratum:\n$$TP_{restr} = 95$$\nThe sensitivity for the restricted-spectrum evaluation is:\n$$\\text{sensitivity}_{\\text{restr}} = \\frac{TP_{restr}}{N'_D} = \\frac{95}{100}$$\n\nThe number of truly non-diseased patients is the number of symptomatic disease-mimicking patients:\n$$N'_{D^c} = 200$$\nThe number of true negatives ($TN_{restr}$) is the number of negative results in this stratum:\n$$TN_{restr} = 140$$\nThe specificity for the restricted-spectrum evaluation is:\n$$\\text{specificity}_{\\text{restr}} = \\frac{TN_{restr}}{N'_{D^c}} = \\frac{140}{200}$$\n\n**3. Net Spectrum-Bias Magnitude ($B$)**\nThe net spectrum-bias magnitude $B$ is defined as:\n$$B = (\\text{sensitivity}_{\\text{restr}} - \\text{sensitivity}_{\\text{full}}) + (\\text{specificity}_{\\text{full}} - \\text{specificity}_{\\text{restr}})$$\nSubstituting the derived fractional values:\n$$B = \\left(\\frac{95}{100} - \\frac{325}{450}\\right) + \\left(\\frac{385}{450} - \\frac{140}{200}\\right)$$\nWe simplify the fractions:\n$\\frac{95}{100} = \\frac{19}{20}$\n$\\frac{325}{450} = \\frac{65}{90} = \\frac{13}{18}$\n$\\frac{385}{450} = \\frac{77}{90}$\n$\\frac{140}{200} = \\frac{14}{20} = \\frac{7}{10}$\n\nSubstituting these simplified fractions into the expression for $B$:\n$$B = \\left(\\frac{19}{20} - \\frac{13}{18}\\right) + \\left(\\frac{77}{90} - \\frac{7}{10}\\right)$$\nTo compute the first term, we find a common denominator of $180$:\n$$\\frac{19}{20} - \\frac{13}{18} = \\frac{19 \\times 9}{180} - \\frac{13 \\times 10}{180} = \\frac{171 - 130}{180} = \\frac{41}{180}$$\nTo compute the second term, we find a common denominator of $90$:\n$$\\frac{77}{90} - \\frac{7}{10} = \\frac{77}{90} - \\frac{7 \\times 9}{90} = \\frac{77 - 63}{90} = \\frac{14}{90} = \\frac{7}{45}$$\nNow, we sum the two terms:\n$$B = \\frac{41}{180} + \\frac{7}{45}$$\nUsing a common denominator of $180$:\n$$B = \\frac{41}{180} + \\frac{7 \\times 4}{180} = \\frac{41 + 28}{180} = \\frac{69}{180}$$\nSimplifying the final fraction by dividing the numerator and denominator by $3$:\n$$B = \\frac{23}{60}$$\nTo obtain the numerical value, we perform the division:\n$$B = \\frac{23}{60} = 0.383333...$$\nRounding to $4$ significant figures, we get $0.3833$.",
            "answer": "$$\\boxed{0.3833}$$"
        },
        {
            "introduction": "Clinicians often use multiple tests to refine a diagnosis. This practice explores two common strategies for combining tests: series testing (requiring all tests to be positive to confirm a disease) and parallel testing (requiring at least one test to be positive to screen for a disease). You will learn to calculate the combined diagnostic power of these strategies using Likelihood Ratios ($LR^{+}$ and $LR^{-}$), a flexible tool that allows you to update disease probability. This exercise demonstrates how to design and evaluate a multi-test algorithm to optimize clinical decision-making .",
            "id": "4954834",
            "problem": "A clinician evaluates a patient for a condition using two independent diagnostic tests administered at the same visit. Test independence is assumed conditional on true disease status. Test $A$ has sensitivity $Se_{A} = 0.92$ and specificity $Sp_{A} = 0.88$. Test $B$ has sensitivity $Se_{B} = 0.80$ and specificity $Sp_{B} = 0.95$. The pre-test probability of disease is $p_{0} = 0.18$ for this patient population.\n\nThe clinician considers two strategies to classify the overall result of testing:\n- Series testing: classify the overall test as positive only if both $A$ and $B$ are positive; otherwise, classify the overall test as negative.\n- Parallel testing: classify the overall test as positive if either $A$ or $B$ is positive; classify as negative only if both are negative.\n\nUsing only the foundational definitions of sensitivity, specificity, and the Likelihood Ratio (LR), and the independence of test results conditional on disease status, do the following:\n1. Derive the combined positive Likelihood Ratio $LR^{+}$ and combined negative Likelihood Ratio $LR^{-}$ for the series strategy and for the parallel strategy.\n2. Using Bayes’ theorem in odds form, convert the pre-test probability $p_{0}$ to pre-test odds and then compute the post-test probability of disease for a patient who receives a positive overall classification under each strategy. Also compute the post-test probability for a patient who receives a negative overall classification under each strategy.\n3. Finally, report the absolute difference in post-test probability (expressed as a decimal) between the series and parallel strategies when the overall classification is positive.\n\nRound your final answer to four significant figures. Express probabilities as decimals (do not use a percentage sign).",
            "solution": "We begin from the core definitions. Sensitivity ($Se$) is the probability of a positive test given disease, and specificity ($Sp$) is the probability of a negative test given no disease. The positive Likelihood Ratio is $LR^{+} = Se / (1 - Sp)$, and the negative Likelihood Ratio is $LR^{-} = (1 - Se) / Sp$. We assume the tests are independent conditional on disease status.\n\nThe given parameters are:\n- Test A: $Se_{A} = 0.92$, $Sp_{A} = 0.88$\n- Test B: $Se_{B} = 0.80$, $Sp_{B} = 0.95$\n- Pre-test probability: $p_{0} = 0.18$\n\nFirst, we derive the combined operating characteristics (sensitivity and specificity) and Likelihood Ratios for each strategy.\n\n**Series Strategy**\nAn overall positive result requires both tests to be positive. An overall negative result occurs if at least one test is negative.\n- Combined Sensitivity ($Se_{\\text{series}}$): The probability that both tests are positive in a diseased person.\n$$Se_{\\text{series}} = Se_{A} \\times Se_{B} = 0.92 \\times 0.80 = 0.736$$\n- Combined Specificity ($Sp_{\\text{series}}$): The probability that at least one test is negative in a non-diseased person. This is 1 minus the probability that both are falsely positive.\n$$Sp_{\\text{series}} = 1 - (1 - Sp_{A})(1 - Sp_{B}) = 1 - (0.12)(0.05) = 1 - 0.006 = 0.994$$\n- From these, we can calculate the Likelihood Ratios:\n$$LR^{+}_{\\text{series}} = \\frac{Se_{\\text{series}}}{1 - Sp_{\\text{series}}} = \\frac{0.736}{1 - 0.994} = \\frac{0.736}{0.006} = \\frac{368}{3}$$\n$$LR^{-}_{\\text{series}} = \\frac{1 - Se_{\\text{series}}}{Sp_{\\text{series}}} = \\frac{1 - 0.736}{0.994} = \\frac{0.264}{0.994} = \\frac{132}{497}$$\n\n**Parallel Strategy**\nAn overall positive result requires at least one test to be positive. An overall negative result requires both tests to be negative.\n- Combined Sensitivity ($Se_{\\text{parallel}}$): The probability that at least one test is positive in a diseased person. This is 1 minus the probability that both are negative.\n$$Se_{\\text{parallel}} = 1 - (1 - Se_{A})(1 - Se_{B}) = 1 - (0.08)(0.20) = 1 - 0.016 = 0.984$$\n- Combined Specificity ($Sp_{\\text{parallel}}$): The probability that both tests are negative in a non-diseased person.\n$$Sp_{\\text{parallel}} = Sp_{A} \\times Sp_{B} = 0.88 \\times 0.95 = 0.836$$\n- From these, we can calculate the Likelihood Ratios:\n$$LR^{+}_{\\text{parallel}} = \\frac{Se_{\\text{parallel}}}{1 - Sp_{\\text{parallel}}} = \\frac{0.984}{1 - 0.836} = \\frac{0.984}{0.164} = 6$$\n$$LR^{-}_{\\text{parallel}} = \\frac{1 - Se_{\\text{parallel}}}{Sp_{\\text{parallel}}} = \\frac{1 - 0.984}{0.836} = \\frac{0.016}{0.836} = \\frac{4}{209}$$\n\nNext, we connect these Likelihood Ratios to post-test probabilities using Bayes’ theorem in odds form. Let pre-test odds be\n$$\\text{odds}_{0} = \\frac{p_{0}}{1 - p_{0}} = \\frac{0.18}{0.82} = \\frac{18}{82} = \\frac{9}{41}.$$\nPost-test odds after a positive classification are $\\text{odds}_{0} \\times LR^{+}$, and after a negative classification are $\\text{odds}_{0} \\times LR^{-}$. Convert odds $\\text{odds}$ to probability $p$ by\n$$p = \\frac{\\text{odds}}{1 + \\text{odds}}.$$\n\nPositive classification:\n- Series strategy:\n$$\\text{odds}_{\\text{series},+} = \\frac{9}{41} \\times \\frac{368}{3} = \\frac{3312}{123},$$\n$$p_{\\text{series},+} = \\frac{\\frac{3312}{123}}{1 + \\frac{3312}{123}} = \\frac{3312}{3312 + 123} = \\frac{3312}{3435} = \\frac{1104}{1145}.$$\n- Parallel strategy:\n$$\\text{odds}_{\\text{parallel},+} = \\frac{9}{41} \\times 6 = \\frac{54}{41},$$\n$$p_{\\text{parallel},+} = \\frac{\\frac{54}{41}}{1 + \\frac{54}{41}} = \\frac{54}{54 + 41} = \\frac{54}{95}.$$\n\nNegative classification (for comparison):\n- Series strategy:\n$$\\text{odds}_{\\text{series},-} = \\frac{9}{41} \\times \\frac{132}{497} = \\frac{1188}{20377},$$\n$$p_{\\text{series},-} = \\frac{\\frac{1188}{20377}}{1 + \\frac{1188}{20377}} = \\frac{1188}{20377 + 1188} = \\frac{1188}{21565}.$$\n- Parallel strategy:\n$$\\text{odds}_{\\text{parallel},-} = \\frac{9}{41} \\times \\frac{4}{209} = \\frac{36}{8569},$$\n$$p_{\\text{parallel},-} = \\frac{\\frac{36}{8569}}{1 + \\frac{36}{8569}} = \\frac{36}{8569 + 36} = \\frac{36}{8605}.$$\n\nFinally, we compute the absolute difference in post-test probability after a positive classification between the series and parallel strategies:\n$$\\Delta = \\left|p_{\\text{series},+} - p_{\\text{parallel},+}\\right| = \\left|\\frac{1104}{1145} - \\frac{54}{95}\\right|.$$\nFind a common denominator:\n$$\\frac{1104}{1145} - \\frac{54}{95} = \\frac{1104 \\times 19}{1145 \\times 19} - \\frac{54 \\times 229}{95 \\times 229} = \\frac{20976}{21755} - \\frac{12366}{21755} = \\frac{8610}{21755}.$$\nReduce by $5$:\n$$\\Delta = \\frac{1722}{4351} \\approx 0.395779\\ldots.$$\n\nRounded to four significant figures and expressed as a decimal,\n$$\\Delta \\approx 0.3958.$$",
            "answer": "$$\\boxed{0.3958}$$"
        }
    ]
}